Form 4 for AEON AEON Biopharma, Inc.
Accepted 2024-09-04 00:00:00 ET · period of report 2024-08-31 · accession 0001104659-24-097061 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-04 | 2024-08-31 | AEON | Carter Eric G | Dir | A - Grant | $0.00 | +36.0K | 36.0K | New | $0 |
| D | 2024-09-04 | 2024-08-31 | AEON | Carter Eric G | Dir | A - Grant | $0.00 | +96.2K | 96.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-08-31 | A | A | 36,021 | $0.00 | 36,021 | D | — | — | (F1) Represents an award of restricted stock units granted on August 31, 2024 (the "Grant Date"), which vests in full on the second anniversary of the Grant Date, subject to the reporting person's continued service through the applicable vesting date. |
| 2 | Derivative | Stock Option | 2024-08-31 | A | A | 96,210 | $0.00 | 96,210 | D | $0.83 · — to 2034-08-30 | 96,210 Class A Common Stock | (F2) Represents an award of stock options granted on August 31, 2024 (the "Grant Date"), which vest and become exercisable in substantially equal monthly installments over the eighteen months following the Grant Date, subject to the reporting person's continued service through the applicable vesting date. |